Navigation Links
Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry
Date:4/28/2011

NEW YORK, April 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry

http://www.reportlinker.com/p0487118/Pharmaceutical-Key-Trends-2011---Brand-Erosion-Post-Patent-Expiry.html

Introduction

Pharma is facing slowing sales growth in the developed pharmaceutical markets, driven by increasing generic competition. However, the speed and severity of brand erosion is by no means equal across countries, prescribing setting, therapy area and formulation type; factors which are of key importance when managing and forecasting branded drug sales.

Features and benefits

* Analyzes brand erosion (in terms of volume and value) in the US, Japan, France, Germany, Italy, Spain, UK, Australia China and Russia

* Assesses brand erosion across the two major prescribing settings (retail and hospital)

* Examines brand erosion across the various different therapy areas

* Analyzes brand erosion according to drug formulation (oral, oral long lasting, parenteral and other formulation types)

Highlights

Brands tended not to experience generic erosion in China following patent expiry since they often face generic competition from the outset, and instead continue to grow both in terms of volume and value.

Brand erosion was greater in terms of speed and severity in the hospital setting most likely reflecting the greater brand loyalty among patients in the retail setting.

In terms of erosion by therapy areas, sales and volume erosion was the greatest among infectious disease, oncology, and cardiovascular small molecule brands.

Your key questions answered

* Evaluate the evolving prescription pharmaceutical landscape and how this is being impacted by generics

* Quantify sales and volume erosion across 10 major pharmaceutical markets according to prescribing setting, therapy areas, and drug formulation

* Assess drivers and resistors for the uptake of generic drugs in each market

Executive Summary

Introduction

Strategic Scoping and Focus

Key Findings

Brand erosion by country

Brand erosion by prescribing setting (retail versus hospital)

Brand erosion by therapy area

Brand erosion by formulation

Overview of drugs analyzed

Related Reports

Upcoming related reports

2. BRAND EROSION ACROSS THE WORLD'S MAJOR MARKETS

Overview of brand erosion across the world's major markets

3. GENERICS MARKET DYNAMICS

Comparison of generic penetration across major pharmaceutical markets

Generics volume uptake

Generics value uptake

Generics market size

4. GENERICS DRIVERS AND RESISTORS

Overview of Generics Drivers and Resistors

US – Generics drivers and resistors

Japan – Generics drivers and resistors

France – Generics drivers and resistors

Germany – Generics drivers and resistors

Italy – Generics drivers and resistors

Spain – Generics drivers and resistors

UK – Generics drivers and resistors

China – Generics drivers and resistors

Brazil – Generics drivers and resistors

India – Generics drivers and resistors

Russia – Generics drivers and resistors

Australia – Generics drivers and resistors

5. BRAND EROSION IN THE RETAIL AND HOSPITAL SETTING

Overview of brand erosion in the retail and hospital setting

Retail and hospital erosion by country

6. BRAND EROSION BY THERAPY AREA

Overview of brand erosion by therapy area

Brand erosion by therapy area – Infectious diseases

Brand erosion by therapy area – Cardiovascular

Brand erosion by therapy area – Oncology

Brand erosion by therapy area – Central Nervous System

Brand erosion by therapy area – Respiratory

Brand erosion by therapy area – Metabolic disorders

Brand erosion by therapy area – Immunology and inflammation

Brand erosion by therapy area – Other

7. BRAND EROSION BY DRUG FORMULATION

Overview of brand erosion by drug formulation

Brand erosion by drug formulation – Oral

Brand erosion by drug formulation – Oral long lasting

Brand erosion by drug formulation – Parenteral

Brand erosion by drug formulation – Other formulations

8. BIBLIOGRAPHY

Publications and online articles

Datamonitor reports and products

APPENDIX

Exchange rates used in this report

Brand erosion – methodology

Datamonitor prescription pharmaceutical definition and therapy area classification

To order this report:

: Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- Story Highlights: , ... health care industry is causing providers to review operating ... offers a suite of solutions for health care providers ... optimization: labor resource analysis, revenue cycle optimization and physician ... and better economics ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
Breaking Medicine News(10 mins):